sitagliptin/metformin hydrochloride sandoz
sandoz d.d. - sitagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/850 mg - metformin and sitagliptin
sitagliptin/metformin hydrochloride sandoz
sandoz d.d. - sitagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg - metformin and sitagliptin
bendamustine hydrochloride boston biopharma
boston biopharma lt, uab - bendamustino hidrochloridas - milteliai infuzinio tirpalo koncentratui - 2,5 mg/ml - bendamustine
benzydamine hydrochloride zentiva
zentiva k.s. - benzidamino hidrochloridas - burnos gleivinės purškalas (tirpalas) - 1,5 mg/ml - benzydamine
benzydamine hydrochloride zentiva
zentiva k.s. - benzidamino hidrochloridas - burnos gleivinės purškalas (tirpalas) - 3 mg/ml - benzydamine
vildagliptin/metformin hydrochloride elvim
sia elvim - vildagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/850 mg - metformin and vildagliptin
vildagliptin/metformin hydrochloride elvim
sia elvim - vildagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg - metformin and vildagliptin
lidocaine hydrochloride instillido
farco-pharma gmbh - lidokaino hidrochloridas - gelis - 20 mg/ml - lidocaine
benzydamine hydrochloride/cetylpyridinium chloride farmak
farmak international sp. z o.o. - benzidamino hidrochloridas/cetilpiridinio chloridas - burnos gleivinės purškalas (tirpalas) - 1,5 mg/5 mg/ml - various
clopidogrel tad
tad pharma gmbh - clopidogrel (as hydrochloride) - peripheral vascular diseases; stroke; myocardial infarction - antitromboziniai vaistai - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.